PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 9 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Flower essential oil exhibited potent antinociceptive activity, reducing acetic acid-induced writhing by 73.88 ± 2.78% and increasing pain withdrawal latency in mice [PMID:36960955].
Flower essential oil demonstrated a potent wound healing effect, achieving 98.08 ± 1.37% wound closure by the 12th day of treatment in a model study [PMID:36960955].
Essential oils and their nanoemulsions showed high larvicidal activity, with nanoemulsions achieving a lower LC50 (88.30 ppm) compared to bulk oil (247.72 ppm) against Culex pipiens [PMID:37960039, PMID:30632272].
Evidence summary
PubMed sources
- 1.PMID: 30812224 (2004) — First Report of Powdery Mildew Caused by Oidium Subgenus Pseudoidium on Lonicera caprifolium in Italy. · Plant disease
- 2.PMID: 36960955 (2024) — Chemical composition and biological activities of Lonicera caprifolium L. (Caprifoliaceae) essential oil. · Natural product research
- 3.PMID: 37960039 (2023) — Sustainable Pest Management Using Novel Nanoemulsions of Honeysuckle and Patchouli Essential Oils against the West Nile Virus Vector, Culex pipiens, under Laboratory and Field Conditions. · Plants (Basel, Switzerland)
- 4.PMID: 38907660 (2025) — Volatile oil constituents, antioxidant and antibacterial activities of Lonicera caprifolium L. in different areas of Iran. · Natural product research
- 5.PMID: 30632272